MMP9 and dermatomyositis: We selected moDCs8, 10 as a surrogate for the MMP9+ CD14+ myeloid cells observed in CLE and DM lesions, given their shared expression of key markers ITGAX (CD11c), CD209, MAFB8 (Fig. 2B, S2A).